Biolife solutions to report first quarter 2024 financial results and business update on may 9, 2024

Bothell, wash., april 30, 2024 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("cgt") and broader biopharma markets, today announced the company's first quarter 2024 financial results will be released after market close on thursday, may 9, 2024.

BLFS Ratings Summary

BLFS Quant Ranking